跳至主要内容
临床试验/NCT01882413
NCT01882413已完成不适用

A Study to Determine the Prevalence of Inflammatory Dry Eye Disease in Patients Prior to Cataract Removal

Allergan0 个研究点目标入组 204 人开始时间: 2013年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Allergan
入组人数
204
主要终点
Percentage of Patients With a Presence of Matrix Metalloproteinase-9 (MMP-9) in the Study Eye

研究概览

简要总结

This study will evaluate the prevalence of inflammatory dry eye disease in patients prior to cataract surgery. No treatment is administered in this study.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Scheduled to undergo cataract removal surgery

排除标准

  • Current use of eye drops or oral medications for allergic conjunctivitis
  • Serious ocular injury, intraocular surgery, or refractive surgery within 6 months in the study eye
  • Use of a contact lens within 4 weeks

结局指标

主要结局

Percentage of Patients With a Presence of Matrix Metalloproteinase-9 (MMP-9) in the Study Eye

时间窗: Up to 60 Days Prior to Surgery

Tear film was collected and a diagnostic test was used to determine the presence of MMP-9 in the study eye.

次要结局

  • Percentage of Participants Suspected of Having Dry Eye With Elevated MMP-9(Up to 60 days prior to cataract surgery)
  • Percentage of Participants With Elevated MMP-9 Without Prior Diagnosis or Physician Recommended Intervention(Up to 60 days prior to cataract surgery)
  • Percentage of Participants With Elevated MMP-9 With Dry Eye Symptoms Without Conjunctival or Corneal Staining(Up to 60 days prior to cataract surgery)
  • Percentage of Participants With Elevated MMP-9 With Dry Eye Symptoms Without Any Signs(Up to 60 days prior to cataract surgery)
  • Percentage of Participants With Elevated MMP-9 With at Least One Dry Eye Sign Without Dry Eye Symptoms(Up to 60 days prior to cataract surgery)
  • Percentage of Participants With Elevated MMP-9 With at Least One Dry Eye Sign and Dry Eye Symptoms(Up to 60 days prior to cataract surgery)
  • Percentage of Participants With Elevated MMP-9 Who Routinely Use Artificial Tears(Up to 60 Days Prior to Surgery)
  • Percentage of Participants With Elevated MMP-9 With Punctal Plugs(Up to 60 Days Prior to Surgery)
  • Percentage of Participants With Elevated MMP-9 With Corneal Staining Grade ≥ 1 and ≥ 2(Up to 60 Days Prior to Surgery)
  • Percentage of Participants With Elevated MMP-9 and an Ocular Surface Disease Index® (OSDI®) > 12, > 22 and ≥ 32(Up to 60 Days Prior to Surgery)

研究者

发起方
Allergan
申办方类型
Industry
责任方
Sponsor

相似试验